These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 7886314)

  • 1. Hodgkin's disease.
    Longo DL; Banks PM; Hoppe RT
    Rev Invest Clin; 1994 Apr; Suppl():73-83. PubMed ID: 7886314
    [No Abstract]   [Full Text] [Related]  

  • 2. New therapies in Hodgkin's lymphoma.
    Bartlett N
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):80, 83. PubMed ID: 16163165
    [No Abstract]   [Full Text] [Related]  

  • 3. First-line treatment of Hodgkin's lymphoma.
    Klimm B; Engert A; Diehl V
    Curr Hematol Rep; 2005 Jan; 4(1):15-22. PubMed ID: 15610655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of Hodgkin's disease.
    Rosenberg SA
    Ann Oncol; 1994; 5 Suppl 2():17-21. PubMed ID: 8204516
    [No Abstract]   [Full Text] [Related]  

  • 6. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
    Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
    Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
    Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in biology, diagnostics, and treatment of Hodgkin's disease.
    Küppers R; Yahalom J; Josting A
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):66-76. PubMed ID: 16399588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's disease following extranodal marginal zone B-cell lymphoma in remission.
    Shimizu K; Hara K; Yatabe Y
    Int J Hematol; 1999 Feb; 69(2):96-100. PubMed ID: 10071458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Controversies in therapy of malignant lymphomas].
    Diehl V; Engert A
    Internist (Berl); 1994 Apr; 35(4):313-22. PubMed ID: 8200756
    [No Abstract]   [Full Text] [Related]  

  • 13. Hodgkin's disease in children.
    Pao WJ; Kun LE
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):345-65. PubMed ID: 2663832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of radiation in the management of Hodgkin's disease: an update.
    Mendenhall NP
    Cancer Invest; 1999; 17(1):47-55. PubMed ID: 10999049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late complications of therapy of Hodgkin's disease: prevention and management.
    Ng AK; Mauch PM
    Curr Hematol Rep; 2004 Jan; 3(1):27-33. PubMed ID: 14695846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
    Bonadonna G; Bonfante V; Viviani S; Di Russo A; Villani F; Valagussa P
    J Clin Oncol; 2004 Jul; 22(14):2835-41. PubMed ID: 15199092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphoma].
    Mohar A; Sobrevilla-Calvo P; Velasquez WS
    Rev Invest Clin; 1997 May; 49 Suppl 1():56-63. PubMed ID: 9380990
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic strategies of Hodgkin's disease].
    Lathan B; Pfreundschuh M; Diehl V
    Internist (Berl); 1993 Feb; 34(2):146-54. PubMed ID: 8454428
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
    Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hodgkin's disease--a curable disease].
    Kotlarek-Haus S; Gabryś K; Sciborski R; Gałazka Z; Jeleń M; Fischer W
    Pol Tyg Lek; 1988 Aug; 43(33):1047-52. PubMed ID: 3244571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.